Catalent Z Score
CTLT   USA Stock  USD 102.08 0.06 0.06% 
Catalent Z Score  Catalent Z Score 
Catalent Z Score Analysis
Catalent's ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..Current Catalent Z Score  3.4 
Most of Catalent's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

Catalent Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Catalent is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Catalent's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Catalent's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Catalent's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
In accordance with the company's disclosures, Catalent has a Z Score of 3.4. This is 49.63% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturersâ€”Specialty & Generic industry. The z score for all United States stocks is 61.01% higher than that of the company.
Catalent Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalent's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics of similar companies.Catalent is currently under evaluation in z score category among related companies.
Catalent Current Valuation Drivers
We derive many important indicators used in calculating different scores of Catalent from analyzing Catalent's financial statements. These drivers represent accounts that assess Catalent's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Catalent's important valuation drivers and their relationship over time.
2017  2018  2019  2020  2021  2022 (projected)  
Net Income Per Employee  7.81 K  11.17 K  15.83 K  33.81 K  30.43 K  32.84 K  
Revenue Per Employee  230.22 K  204.72 K  222 K  231.1 K  207.99 K  200.05 K  
Average Assets  4.31 B  4.9 B  6.79 B  8.52 B  9.79 B  10.57 B  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  453.5 M  500 M  640 M  1.11 B  1.28 B  1.38 B  
Earnings Before Interest Taxes and Depreciation Amortization USD  453.5 M  500 M  640 M  1.11 B  1.28 B  1.38 B  
Earnings before Tax  152 M  160 M  260 M  715 M  822.25 M  887.16 M  
Average Equity  1.05 B  1.6 B  2.11 B  3.54 B  4.07 B  4.39 B  
Enterprise Value  7.97 B  9.86 B  13.94 B  20.65 B  23.75 B  25.63 B  
Free Cash Flow  199.8 M  31 M  (26 M)  (253 M)  (227.7 M)  (233.69 M)  
Invested Capital  4.32 B  4.98 B  5.59 B  6.92 B  7.96 B  6.67 B  
Invested Capital Average  4.13 B  4.2 B  5.31 B  6.32 B  7.27 B  6.2 B  
Market Capitalization  5.59 B  7.9 B  11.35 B  18.42 B  21.18 B  22.85 B  
Tangible Asset Value  2.59 B  3.03 B  4.42 B  5.78 B  6.64 B  7.17 B  
Working Capital  663.4 M  725.1 M  1.4 B  1.72 B  1.98 B  2.14 B 
Catalent Fundamentals
Return On Equity  14.79 %  
Return On Asset  4.97 %  
Profit Margin  14.27 %  
Operating Margin  17.28 %  
Current Valuation  23.14 B  
Shares Outstanding  171.19 M  
Shares Owned by Insiders  0.27 %  
Shares Owned by Institutions  99.29 %  
Number of Shares Shorted  1.33 M  
Price to Earning  34.07 X  
Price to Book  4.60 X  
Price to Sales  4.44 X  
Revenue  4.18 B  
Gross Profit  1.35 B  
EBITDA  1.02 B  
Net Income  544 M  
Cash and Equivalents  2.02 B  
Cash per Share  11.79 X  
Total Debt  4.32 B  
Debt to Equity  0.98 %  
Current Ratio  3.59 X  
Book Value Per Share  23.51 X  
Cash Flow from Operations  446 M  
Short Ratio  1.24 X  
Earnings Per Share  3.18 X  
Price to Earnings To Growth  1.97 X  
Number of Employees  17.3 K  
Beta  1.34  
Market Capitalization  18.53 B  
Total Asset  3.09 B  
Retained Earnings  (897.59 M)  
Working Capital  399 M  
Current Asset  790.2 M  
Current Liabilities  391.2 M  
Z Score  3.4 
About Catalent Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Catalent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, proteinbased biologics, cell and gene therapies, and consumer health products worldwide. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey. Catalent operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 17300 people.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Catalent without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Recommendations Now
Analyst RecommendationsAnalyst recommendations and target price estimates broken down by several categories 
All Next  Launch Module 
Pair Trading with Catalent
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalent position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will appreciate offsetting losses from the drop in the long position's value.Catalent Pair Correlation
Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Catalent and Bausch Health Companies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better riskadjusted return
Run Pair Correlation 
Continue to Catalent Piotroski F Score and Catalent Valuation analysis. Note that the Catalent information on this page should be used as a complementary analysis to other Catalent's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Catalent Stock analysis
When running Catalent price analysis, check to measure Catalent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalent is operating at the current time. Most of Catalent's value examination focuses on studying past and present price action to predict the probability of Catalent's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Catalent's price. Additionally, you may evaluate how the addition of Catalent to your portfolios can decrease your overall portfolio volatility.
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities  Go  
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency  Go  
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios  Go  
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital  Go  
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios  Go 
The market value of Catalent is measured differently than its book value, which is the value of Catalent that is recorded on the company's balance sheet. Investors also form their own opinion of Catalent's value that differs from its market value or its book value, called intrinsic value, which is Catalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catalent's market value can be influenced by many factors that don't directly affect Catalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catalent's value and its price as these two are different measures arrived at by different means. Investors typically determine Catalent value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.